FindTrial
Sign In

Study to evaluate relation between side effects of first line chemotherapy in breast cancer patients with Prakruti.

An observational survey study to evaluate relation between side effects of first line chemotherapy in breast cancer patients with Prakruti.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037041
Enrollment
76
Registered
2021-10-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

None listed

Sponsors

College of Ayurved and Research Centre Akurdi Pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Breast cancer patients receiving Chemotherapy.

Exclusion criteria

Exclusion criteria: Breast cancer patients receiving Chemotherapy but in very critical condition.

Design outcomes

Primary

MeasureTime frame
Conclusion will be strictly based on statistical analysisTimepoint: Every 6 months—

Secondary

MeasureTime frame
Which prakruti has more side effects of first line of chemotherapy in breast cancer.Timepoint: Every 6 months—

Countries

India

Contacts

Public ContactDrSagar Bangar

PDEAS College of Ayurved and Research Centre

swati13mahajan@gmail.com9975587176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026